CH
Craig Hill
Director Radiopharmacutical Development And Translation at Spectronrx
View Craig's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Feb 2020 - Present · 4 years and 10 months
Director Radiopharmacutical Development And Translation
Feb 2023 - Present · 1 years and 10 months
Radiochemist
Feb 2020 - Mar 2023 · 3 years and 1 months
Manzanita Pharmaceuticals
Advisor
Present
Company Details
11-50 Employees
SpectronRx is a CDMO that is FDA and EMA-inspected. We are licensed to handle multiple pharmaceutical-grade Therapeutic and Diagnostic isotopes, including Pb-212, Lu-177, Ac-225, and I-131, for various clinical applications. SpectronRx operates under a quality program that has been inspected by the FDA with approved drugs FDG, NaF and Ammonia. SpectronRx provides labeling and contract manufacturing services related to Lu-177, Ac-225, I-131, I-124, I-111, Zr-89, Copper-64 and Fluorine-18.
Year Founded
2004
Social Media
Linkedin
Industry
Pharmaceutical Manufacturing, Scientific Research and Development Services, Services
HQ Location
Indianapolis, South Bend, Bunker Hill Indiana and Danbury, CT, 46268, US
Keywords
cGMP complianceUSP <823>21 CFR Part 212Lu-177Ac-225I-131FDANuclear MedicineRadiopharmaceuticalsCDMO
Discover More About Cleveland Clinic

Find verified contacts of Craig Hill in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.